# Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer

> **NCT00807079** · PHASE1,PHASE2 · COMPLETED · sponsor: **ARCAGY/ GINECO GROUP** · enrollment: 12 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** topotecan hydrochloride

## Key facts

- **NCT ID:** NCT00807079
- **Lead sponsor:** ARCAGY/ GINECO GROUP
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-05
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807079, "Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00807079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*